Non Animal Testing, Alternative Test Methods, In Vitro Toxicology, IIVS | IIVS at the World Congress Alternatives and Animal Use in the Life Sciences

19 Jul IIVS at the World Congress Alternatives and Animal Use in the Life Sciences

Posted at 19:33h in Uncategorized by Jane Ryan 0 Comments

1 Like

We are looking forward to attending the upcoming Tenth World Congress: Alternatives and Animal Use in the Life Sciences, August 20-24, 2017 in Seattle, WA. We have several presentations and posters at the meeting, listed below. If you will be attending, please stop by our booth – #202 – and talk with our officers and staff. We look forward to seeing you!

Presentations

Tuesday, August 22, 2017
10:00 am – Noon

Session IX-4: Global Regulatory Updates

Collaborative industry and regulatory efforts to implement alternative methods in China (Abstract #131)
10:45 – 11:00 am
Erin Hill

Tuesday, August 22, 2017
3:15 – 5:00 pm

Session IX-7: Examining the Gap Between Regulatory Acceptance and Industry Use of Alternative Methods

Why Regulatory Acceptance Doesn’t Necessarily Result in Industry Use of Alternatives (Abstract #202)
Erin Hill
Presentation Time: 3:15 – 3:30 pm

Wednesday, August 23, 2017
10 am – Noon

Session IV-1: Predictive Safety Approaches Role in the Design of Inherently Safer Chemicals

The Practical Application of In Vitro Pulmonary Models to Assess Acute and Chronic Effects of Toxic Exposure
(Abstract #206)
Rodger Curren
Presentation time: 10:45 – 11:00 am

Thursday, August 24, 2017
10:00 am – Noon

Session IX-5: Global Regulatory Harmonization

Industry and Regulatory Collaboration to Help Modernize the US EPA 6 Pack: Revised Prediction Model of the Skin Irritation Test (SIT, OECD TG 439) to Predict EPA Hazard Categories (Abstract #110)
Presentation time: 11:15 – 11:30 am

Session IX-6: 3Rs Communication and Advocacy

Sharing Technology and Expertise: A US Society Promotes the Use of Alternatives Through its Membership Activities
(Abstract #498)
Erin Hill
Presentation Time: 11:25 – 11:40 am

Posters

Session II: Lessons Learned – Regulatory Acceptance

Non-animal Testing Approach to Address Biocompatibility Testing of Medical Devices Required by the United States Food and Drug Administration (US FDA) (Abstract #129)

Erin Hill

Quality Considerations: Redefining Test Systems from Animals to Tissues and Beyond (Abstract #335)

Amanda Ulrey

Session VI: Communicating and Utilizing the 3Rs in Academia, Education & Research – Education

Introducing the 3R Concepts into Pre-college Classrooms (Abstract #581)

Nicole Green, Gertrude-Emilia Costin, Adele Miller, Sue Leary, Katherine Lewis

IIVS at the World Congress Alternatives and Animal Use in the Life Sciences